This document has not been cited yet.

1. Agency for Healthcare Research and Quality, 1996 Medical Expenditure Panel Survey. 2001 :
   Paper not yet in RePEc: Add citation now
   
2. ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. 2002 Journal of the American Medical Association. 288 2981-2997
   Paper not yet in RePEc: Add citation now
   

3. Basu, A. ; Manning, W.G. ; Mullahy, J. Comparing alternative models: log vs Cox proportional hazard?. 2004 Health Economics. 13 749-765

4. Berndt, E.R. ; Bir, A. ; Busch, S.H. ; Frank, R.G. ; Normand, S.L.T. The medical treatment of depression. 1991–1996: productive inefficiency, expected outcome variations, and price indexes. 2002 Journal of Health Economics. 21 373-396
   Paper not yet in RePEc: Add citation now
   
5. Blood Pressure Lowering Treatment Trialists’ Collaboration Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. 2008 British Medical Journal. 336 1121-1123
   Paper not yet in RePEc: Add citation now
   
6. Box, G.E.P. ; Cox, D.R. An analysis of transformations. 1964 Journal of Royal Statistical Society Series B. 26 211-246
   Paper not yet in RePEc: Add citation now
   

7. Buntin, M.B. ; Zaslavsky, A.M. Too much ado about two-part models and transformation?: Comparing methods of modeling Medicare expenditures. 2004 Journal of Health Economics. 23 525-542

8. Catlin, A. ; Cowan, C. ; Hartman, M. ; Heffler, S. National health spending in 2006: a year of change for prescription drugs. 2008 Health Affairs. 27 14-29
   Paper not yet in RePEc: Add citation now
   

9. Chandra, A., Gruber, J., McKnight, R., 2007. Patient cost-sharing, hospitalization offsets, and the design of optimal health insurance for the elderly. NBER Working Paper No. 12972, March.

10. Cutler, D.M. ; McClellan, M. ; Newhouse, J.P. ; Remler, D. Are medical prices declining?: evidence from heart attack treatments. 1998 Quarterly Journal of Economics. 113 991-1024

11. Dahlof, B. ; Sever, P. ; Poulter, N. ; Wedel, H. ; Beevers, D. ; Caulfield, M. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. 2005 The Lancet. 366 895-906
    Paper not yet in RePEc: Add citation now
    

12. Duan, N. ; Manning, W.G. ; Morris, C.N. ; Newhouse, J.P. A comparison of alternative models for the demand for medical care. 1983 Journal of Business and Economic Statistics. 1 115-126

13. Duggan, M. Do new prescription drugs pay for themselves?: the case of second-generation antipsychotics. 2005 Journal of Health Economics. 24 1-31

14. Dupont, A.G. The place of diuretics in the treatment of hypertension: a historical review of classical experience over 30 years. 1993 Cardiovascular Drugs and Therapy. 7 55-62
    Paper not yet in RePEc: Add citation now
    

15. Frank, R.G., McGuire, T.G., Normand, S.L.T., 2006. Cost-offsets of new medications for treatment of schizophrenia. NBER Working Paper No. 12643, November.

16. Gaynor, M. ; Li, J. ; Vogt, W.B. Substitution, Spending Offsets, and Prescription Drug Benefit Design. 2007 Forum for Health Economics & Policy:

17. Hodgson, T.A. ; Cai, L. Medical care expenditures for hypertension, its complications, and its comorbidities. 2001 Medical Care. 39 599-615
    Paper not yet in RePEc: Add citation now
    
18. Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure, The fifth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 1993 Archives of Internal Medicine. 153 154-183
    Paper not yet in RePEc: Add citation now
    
19. Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure, The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2003 Journal of the American Medical Association. 289 2560-2572
    Paper not yet in RePEc: Add citation now
    
20. Joint National Committee on Prevention Detection, Evaluation, Treatment of High Blood Pressure, The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 1997 Archives of Internal Medicine. 157 2413-2446
    Paper not yet in RePEc: Add citation now
    
21. Lichtenberg, F.R Are the benefits of newer drugs worth their cost?: evidence from the 1996 MEPS. 2001 Health Affairs. 20 241-251
    Paper not yet in RePEc: Add citation now
    

22. Lichtenberg, F.R. Benefits and costs of newer drugs: an update. 2007 Managerial and Decision Economics. 28 485-490

23. Lichtenberg, F.R. Effects of new drugs on overall health spending: Frank Lichtenberg responds. 2007 Health Affairs. 26 887-890
    Paper not yet in RePEc: Add citation now
    

24. Lichtenberg, F.R. The impact of new drugs on US longevity and medical expenditure, 1990–2003: evidence from longitudinal, disease-level data. 2007 AEA Papers and Proceedings. 97 438-443

25. Lichtenberg, F.R. ; Grootendorst, P. ; Van Audenrode, M. ; Latremouille-Viau, D. ; Lefebvre, P. The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data. 2009 Value Health. 12 847-856
    Paper not yet in RePEc: Add citation now
    

26. Lichtenberg, F.R., 2004. The effect of drug vintage on survival: micro evidence from Puerto Rico's Medicaid Program. NBER Working Paper No. 10884, November.

27. Manning, W.G. ; Mullahy, J. Estimating log models: to transform or not to transform?. 2001 Journal of Health Economics. 20 461-494

28. Miller, G.E. ; Moeller, J.F. ; Stafford, R.S. New cardiovascular drugs: patterns of use and association with non-drug health expenditures. 2006 Inquiry. 42 397-412
    Paper not yet in RePEc: Add citation now
    
29. Mosby's, Mosby's Drug Consult. 2006 Mosby's: St. Louis
    Paper not yet in RePEc: Add citation now
    
30. Neumann, P.J. ; Sandberg, E.A. ; Bell, C.M. ; Stone, P.W. ; Chapman, R.H. Are pharmaceuticals cost-effective?: a review of the evidence. 2000 Health Affairs. 19 92-109
    Paper not yet in RePEc: Add citation now
    
31. Saseen, J.J. ; MacLaughlin, E.J. ; Westfall, J.M. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers. 2003 Journal of the American Board of Family Medicine. 16 156-164
    Paper not yet in RePEc: Add citation now
    
32. Tamblyn, R. ; Laprise, R. ; Hanley, J.A. ; Abrahamowicz, M. ; Scott, S. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. 2001 Journal of the American Medical Association. 285 421-429
    Paper not yet in RePEc: Add citation now
    
33. Thorpe, K.E. ; Florence, C.S. ; Joski, P. Which medical conditions account for the rise in health care spending?. 2004 Health Affairs. -
    Paper not yet in RePEc: Add citation now
    
34. Writing Group for the Women's Health Initiative Investigators Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. 2002 Journal of the American Medical Association. 288 321-333
    Paper not yet in RePEc: Add citation now
    
35. Zhang, Y. ; Soumerai, S.B. Do newer prescription drugs pay for themselves? A reassessment of the evidence. 2007 Health Affairs. 26 880-886
    Paper not yet in RePEc: Add citation now
    

1. The impact of a national formulary expansion on diabetics. (2022). Serna, Natalia ; McNamara, Cici.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:11:p:2311-2332.

   Full description at Econpapers || Download paper

2. Parental decisions to divorce and have additional children among families with children with cerebral palsy: Evidence from Swedish longitudinal and administrative data. (2022). Gerdtham, Ulf-G. ; Muller, Vibeke ; Jarl, Johan ; Alrikssonschmidt, Ann.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:10:p:2170-2186.

   Full description at Econpapers || Download paper

3. An Estimated Analysis of Willingness to Wait Time to Pay Rice Agricultural Insurance Premiums Using Cox’s Proportional Hazards Model. (2022). Hidayat, Yuyun ; Purwandari, Titi ; Khairunnisa, Nida ; Subartini, Betty ; Sambas, Aceng.
   In: Mathematics.
   RePEc:gam:jmathe:v:10:y:2022:i:21:p:3935-:d:951112.

   Full description at Econpapers || Download paper

4. Heterogeneity in end of life health care expenditure trajectory profiles. (2022). Santos, Rita ; Rice, Nigel ; Kasteridis, Panagiotis.
   In: Journal of Economic Behavior & Organization.
   RePEc:eee:jeborg:v:204:y:2022:i:c:p:221-251.

   Full description at Econpapers || Download paper

5. Quasilinear‐mean regression. (2022). Gorajek, Adam.
   In: Journal of Economic Surveys.
   RePEc:bla:jecsur:v:36:y:2022:i:5:p:1288-1310.

   Full description at Econpapers || Download paper

6. Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder. (2021). Lozano-Ortega, Greta ; Walker, David R ; Schermer, Carol R ; Rogula, Basia ; Deighton, Alison M ; Szabo, Shelagh M ; Campbell, Noll L ; Gooch, Katherine L.
   In: PharmacoEconomics - Open.
   RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00215-w.

   Full description at Econpapers || Download paper

7. Geographic disparities in COVID-19 infections and deaths: The role of transportation. (2021). Zare, Hossein ; Gaskin, Darrell J ; Delarmente, Benjo A.
   In: Transport Policy.
   RePEc:eee:trapol:v:102:y:2021:i:c:p:35-46.

   Full description at Econpapers || Download paper

8. Survey modes comparison in contingent valuation: Internet panels and mail surveys. (2020). Mentzakis, Emmanouil ; Ryan, Mandy ; Bond, Christine ; Matheson, Catriona.
   In: Health Economics.
   RePEc:wly:hlthec:v:29:y:2020:i:2:p:234-242.

   Full description at Econpapers || Download paper

9. A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis. (2019). Rosenberg, Marjorie A ; Levy, Joseph F.
   In: Medical Decision Making.
   RePEc:sae:medema:v:39:y:2019:i:5:p:593-604.

   Full description at Econpapers || Download paper

10. The Well-meaning Economist. (2019). Gorajek, Adam.
    In: RBA Research Discussion Papers.
    RePEc:rba:rbardp:rdp2019-08.

    Full description at Econpapers || Download paper

11. Medical costs, Cesarean delivery rates, and length of stay in specialty hospitals vs. non-specialty hospitals in South Korea. (2017). Kim, Sun Jung ; Ju, Seung ; Han, Kyu-Tae ; Park, Eun-Cheol.
    In: PLOS ONE.
    RePEc:plo:pone00:0188612.

    Full description at Econpapers || Download paper

12. A quasi-Monte-Carlo comparison of parametric and semiparametric regression methods for heavy-tailed and non-normal data: an application to healthcare costs. (2016). Rice, Nigel ; Jones, Andrew ; Moore, Peter T ; Lomas, James.
    In: Journal of the Royal Statistical Society Series A.
    RePEc:bla:jorssa:v:179:y:2016:i:4:p:951-974.

    Full description at Econpapers || Download paper

13. Healthcare Cost Regressions: Going Beyond the Mean to Estimate the Full Distribution. (2015). Rice, Nigel ; Lomas, James ; Jones, Andrew.
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:9:p:1192-1212.

    Full description at Econpapers || Download paper

14. In Memoriam: Willard G. Manning, 1946‐2014. (2015). Mullahy, John.
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:3:p:253-257.

    Full description at Econpapers || Download paper

15. Statistical models for the analysis of skewed healthcare cost data: a simulation study. (2015). Angali, Kambiz ; Pourmotahari, Fatemeh ; Malehi, Amal .
    In: Health Economics Review.
    RePEc:spr:hecrev:v:5:y:2015:i:1:p:1-16:10.1186/s13561-015-0045-7.

    Full description at Econpapers || Download paper

16. Inpatient Hospitalization Costs: A Comparative Study of Micronesians, Native Hawaiians, Japanese, and Whites in Hawai‘i. (2015). Sentell, Tetine ; Yamada, Seiji ; Hagiwara, Megan ; Miyamura, Jill ; Juarez, Deborah Taira.
    In: IJERPH.
    RePEc:gam:jijerp:v:13:y:2015:i:1:p:29-:d:61051.

    Full description at Econpapers || Download paper

17. A meta-analysis of education effects on chronic disease: The causal dynamics of the Population Education Transition Curve. (2015). Smith, William C. ; Horvatek, Renata ; Anderson, Emily ; Baker, David P. ; Salinas, Daniel.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:127:y:2015:i:c:p:29-40.

    Full description at Econpapers || Download paper

18. Going Beyond the Mean in Healthcare Cost Regressions: a Comparison of Methods for Estimating the Full Conditional Distribution. (2014). Rice, Nigel ; Lomas, James ; Jones, Andrew.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:14/26.

    Full description at Econpapers || Download paper

19. STATISTICAL METHODS FOR COST‐EFFECTIVENESS ANALYSES THAT USE OBSERVATIONAL DATA: A CRITICAL APPRAISAL TOOL AND REVIEW OF CURRENT PRACTICE. (2013). Kreif, Noemi ; Sadique, Zia M. ; Grieve, Richard.
    In: Health Economics.
    RePEc:wly:hlthec:v:22:y:2013:i:4:p:486-500.

    Full description at Econpapers || Download paper

20. Modeling healthcare costs in simultaneous presence of asymmetry, heteroscedasticity and correlation. (2013). Merletti, Franco ; Pagano, Eva ; Gregori, Dario ; Desideri, Alessandro ; Ferrando, Alberto ; Berchialla, Paola ; Baldi, Ileana.
    In: Journal of Applied Statistics.
    RePEc:taf:japsta:v:40:y:2013:i:2:p:298-310.

    Full description at Econpapers || Download paper

21. Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain. (2012). Costi, Maria ; Reviriego, Jesus ; Salvador, Javier ; Nicolay, Claudia ; Valladares, Amparo ; Dilla, Tatiana.
    In: Applied Health Economics and Health Policy.
    RePEc:spr:aphecp:v:10:y:2012:i:6:p:417-430.

    Full description at Econpapers || Download paper

22. The Impact of a Public Option in the Health Insurance Market. (2012). Barbos, Andrei ; Deng, YI.
    In: MPRA Paper.
    RePEc:pra:mprapa:40849.

    Full description at Econpapers || Download paper

23. A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data. (2012). Stargardt, Tom ; Schreyögg, Jonas ; Schreygg, Jonas.
    In: Health Policy.
    RePEc:eee:hepoli:v:105:y:2012:i:2:p:110-118.

    Full description at Econpapers || Download paper

24. Applying Beta-type Size Distributions to Healthcare Cost Regressions. (2011). Rice, Nigel ; Lomas, James ; Jones, Andrew.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:11/31.

    Full description at Econpapers || Download paper

25. Review of statistical methods for analysing healthcare resources and costs. (2011). Thompson, Simon G. ; Mihaylova, Borislava ; O'Hagan, Anthony ; Briggs, Andrew.
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:8:p:897-916.

    Full description at Econpapers || Download paper

26. Models For Health Care. (2010). Jones, Andrew.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:10/01.

    Full description at Econpapers || Download paper

27. Is newer always better? Re-evaluating the benefits of newer pharmaceuticals. (2010). Law, Michael R. ; Grepin, Karen A..
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:5:p:743-750.

    Full description at Econpapers || Download paper

28. Estimating Lifetime or Episode-of-illness Costs. (2009). Basu, Anirban ; Manning, W. G, .
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:09/12.

    Full description at Econpapers || Download paper

29. Modelling health expenditure at the household level in Greece. (2009). Tsakloglou, Panos ; Mitrakos, Theo ; Matsaganis, Manos.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:10:y:2009:i:3:p:329-336.

    Full description at Econpapers || Download paper

30. Modelling Household Expenditure on Health Care in Greece. (2008). Tsakloglou, Panos ; Mitrakos, Theo ; Matsaganis, Manos.
    In: Working Papers.
    RePEc:bog:wpaper:68.

    Full description at Econpapers || Download paper

31. Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients. (2007). URZUA, SERGIO ; Navarro, Salvador ; Heckman, James ; Basu, Anirban.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:07/07.

    Full description at Econpapers || Download paper

32. Use of instrumental variables in the presence of heterogeneity and self‐selection: an application to treatments of breast cancer patients. (2007). URZUA, SERGIO ; Heckman, James ; Navarrolozano, Salvador ; Basu, Anirban.
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:11:p:1133-1157:a.

    Full description at Econpapers || Download paper

33. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. (2007). Urzua, Sergio ; Basu, Anirban.
    In: Health Economics.
    RePEc:wly:hlthec:v:16:y:2007:i:11:p:1133-1157.

    Full description at Econpapers || Download paper

34. Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity. (2006). Basu, Anirban ; Rathouz, Paul J. ; Arondekar, Bhakti V..
    In: Health Economics.
    RePEc:wly:hlthec:v:15:y:2006:i:10:p:1091-1107.

    Full description at Econpapers || Download paper

35. Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. (2006). Thompson, Simon G. ; Nixon, Richard M. ; Grieve, Richard.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:25:y:2006:i:6:p:1015-1028.

    Full description at Econpapers || Download paper

36. Generalized modeling approaches to risk adjustment of skewed outcomes data. (2005). Mullahy, John ; Basu, Anirban.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:24:y:2005:i:3:p:465-488.

    Full description at Econpapers || Download paper

37. Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data. (2003). Mullahy, John ; Basu, Anirban.
    In: NBER Technical Working Papers.
    RePEc:nbr:nberte:0293.

    Full description at Econpapers || Download paper

Report date: 2025-10-04 01:49:42 || Missing content? Let us know